ZA939230B - Carboxylic acid derivatives pharmaceutical compositions containing these compounds and processes for preparing them - Google Patents
Carboxylic acid derivatives pharmaceutical compositions containing these compounds and processes for preparing themInfo
- Publication number
- ZA939230B ZA939230B ZA939230A ZA939230A ZA939230B ZA 939230 B ZA939230 B ZA 939230B ZA 939230 A ZA939230 A ZA 939230A ZA 939230 A ZA939230 A ZA 939230A ZA 939230 B ZA939230 B ZA 939230B
- Authority
- ZA
- South Africa
- Prior art keywords
- preparing
- compounds
- processes
- carboxylic acid
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/38—Halogen atoms or nitro radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Indole Compounds (AREA)
- Pyridine Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4241632A DE4241632A1 (de) | 1992-12-10 | 1992-12-10 | Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA939230B true ZA939230B (en) | 1995-06-09 |
Family
ID=6474905
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA939230A ZA939230B (en) | 1992-12-10 | 1993-12-09 | Carboxylic acid derivatives pharmaceutical compositions containing these compounds and processes for preparing them |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0604800A1 (xx) |
| JP (1) | JPH06239817A (xx) |
| KR (1) | KR940014330A (xx) |
| CN (1) | CN1094035A (xx) |
| AU (1) | AU5230693A (xx) |
| CA (1) | CA2111035A1 (xx) |
| CZ (1) | CZ270593A3 (xx) |
| DE (1) | DE4241632A1 (xx) |
| FI (1) | FI935513A (xx) |
| HU (1) | HU9303521D0 (xx) |
| IL (1) | IL107956A0 (xx) |
| MX (1) | MX9307781A (xx) |
| NO (2) | NO934501L (xx) |
| NZ (1) | NZ250391A (xx) |
| PL (1) | PL301396A1 (xx) |
| SK (1) | SK128193A3 (xx) |
| ZA (1) | ZA939230B (xx) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4326344A1 (de) * | 1993-08-05 | 1995-02-09 | Thomae Gmbh Dr K | Carbonamide, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
| CA2171850A1 (en) * | 1994-07-15 | 1996-02-01 | Kiyoaki Katano | Novel compound having platelet aggregation inhibitor effect |
| GB9514160D0 (en) * | 1994-07-25 | 1995-09-13 | Zeneca Ltd | Aromatic compounds |
| GB9417532D0 (en) * | 1994-08-31 | 1994-10-19 | Zeneca Ltd | Aromatic compounds |
| GB9420557D0 (en) * | 1994-10-12 | 1994-11-30 | Zeneca Ltd | Aromatic compounds |
| US6069143A (en) * | 1994-12-20 | 2000-05-30 | Smithkline Beecham Corporation | Fibrinogen receptor antagonists |
| TW502026B (en) * | 1995-06-20 | 2002-09-11 | Zeneca Ltd | Aromatic compounds useful as antagonists of e-type prostaglandins, processes for the preparation thereof, pharmaceutical compositions comprising the compounds, and intermediates |
| TW434240B (en) * | 1995-06-20 | 2001-05-16 | Zeneca Ltd | Aromatic compounds, preparation thereof and pharmaceutical composition comprising same |
| EP0752421B1 (en) * | 1995-07-07 | 2005-10-12 | AstraZeneca AB | Ortho-substituted aromatic compounds, containing three (het)aryl moieties, their preparation and their use as prostaglandin E2-(PGE2)-antagonists |
| DE19614204A1 (de) * | 1996-04-10 | 1997-10-16 | Thomae Gmbh Dr K | Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung |
| US5854245A (en) * | 1996-06-28 | 1998-12-29 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
| WO1998037068A1 (en) * | 1997-02-21 | 1998-08-27 | Bristol-Myers Squibb Company | Benzoic acid derivatives and related compounds as antiarrhythmic agents |
| EP1379520B2 (en) | 2001-02-23 | 2014-04-09 | Merck Sharp & Dohme Corp. | N-substituted nonaryl-heterocyclic nmda/nr2b antagonists |
| DK1599468T3 (da) | 2003-01-14 | 2008-02-04 | Arena Pharm Inc | 1,2,3-trisubstituerede aryl- og heteroarylderivater som modulatorer af metabolisme og forebyggelse og behandling af forstyrrelser forbundet dermed såsom diabetes og hyperglykæmi |
| CN1751038A (zh) * | 2003-02-24 | 2006-03-22 | 艾尼纳制药公司 | 作为葡萄糖代谢调节剂的经取代芳基和杂芳基衍生物及葡萄糖代谢失调的预防和治疗 |
| US7592360B2 (en) | 2003-06-04 | 2009-09-22 | Merck & Co., Inc. | 3-fluoro-piperidines as NMDA/NR2B antagonists |
| AR045047A1 (es) | 2003-07-11 | 2005-10-12 | Arena Pharm Inc | Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos |
| BRPI0508098A (pt) | 2004-02-27 | 2007-07-17 | Amgen Inc | compostos, composições farmacêuticas e métodos para uso no tratamento de distúrbios metabólicos |
| JP4875978B2 (ja) * | 2004-03-15 | 2012-02-15 | 武田薬品工業株式会社 | アミノフェニルプロパン酸誘導体 |
| MY148521A (en) | 2005-01-10 | 2013-04-30 | Arena Pharm Inc | Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto |
| DOP2006000010A (es) | 2005-01-10 | 2006-07-31 | Arena Pharm Inc | Procedimiento para preparar eteres aromáticos |
| US7465804B2 (en) | 2005-05-20 | 2008-12-16 | Amgen Inc. | Compounds, pharmaceutical compositions and methods for their use in treating metabolic disorders |
| EP1924546A1 (en) | 2005-09-14 | 2008-05-28 | Amgen, Inc | Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders |
| US7714008B2 (en) | 2006-09-07 | 2010-05-11 | Amgen Inc. | Heterocyclic GPR40 modulators |
| EP2061760A1 (en) | 2006-09-07 | 2009-05-27 | Amgen, Inc | Benzo-fused compounds for use in treating metabolic disorders |
| WO2008130514A1 (en) | 2007-04-16 | 2008-10-30 | Amgen Inc. | Substituted biphenyl phenoxy-, thiophenyl- and aminophenylpropanoic acid gpr40 modulators |
| WO2009048527A1 (en) | 2007-10-10 | 2009-04-16 | Amgen Inc. | Substituted biphenyl gpr40 modulators |
| WO2009111056A1 (en) | 2008-03-06 | 2009-09-11 | Amgen Inc. | Conformationally constrained carboxylic acid derivatives useful for treating metabolic disorders |
| US8748462B2 (en) | 2008-10-15 | 2014-06-10 | Amgen Inc. | Spirocyclic GPR40 modulators |
| SG188548A1 (en) | 2010-09-22 | 2013-04-30 | Arena Pharm Inc | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
| TW201329025A (zh) | 2011-11-01 | 2013-07-16 | Astex Therapeutics Ltd | 醫藥化合物 |
| EP3242666A1 (en) | 2015-01-06 | 2017-11-15 | Arena Pharmaceuticals, Inc. | Methods of treating conditions related to the s1p1 receptor |
| JP6838744B2 (ja) | 2015-06-22 | 2021-03-03 | アリーナ ファーマシューティカルズ， インコーポレイテッド | Ｓ１Ｐ１レセプター関連障害における使用のための（Ｒ）−２−（７−（４−シクロペンチル−３−（トリフルオロメチル）ベンジルオキシ）−１，２，３，４−テトラヒドロシクロペンタ［ｂ］インドール−３−イル）酢酸（化合物１）の結晶性Ｌ−アルギニン塩 |
| KR20190116416A (ko) | 2017-02-16 | 2019-10-14 | 아레나 파마슈티칼스, 인크. | 원발 담즙성 담관염을 치료하기 위한 화합물 및 방법 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4402975A (en) * | 1980-07-21 | 1983-09-06 | Teijin Limited | Aminocarboxylic acids, amino alcohols, or the derivatives thereof, processes for production thereof, and pharmaceutical uses thereof |
| DE3718638A1 (de) * | 1987-06-04 | 1988-12-22 | Thomae Gmbh Dr K | Neue phenylethanolamine, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
| US5039805A (en) * | 1988-12-08 | 1991-08-13 | Hoffmann-La Roche Inc. | Novel benzoic and phenylacetic acid derivatives |
| NZ239876A (en) * | 1990-09-27 | 1993-12-23 | Merck & Co Inc | Glycyl-b-alanine derivatives and pharmaceutical compositions thereof. |
| DE4035961A1 (de) * | 1990-11-02 | 1992-05-07 | Thomae Gmbh Dr K | Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
| DE4102024A1 (de) * | 1991-01-24 | 1992-07-30 | Thomae Gmbh Dr K | Biphenylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
| DE4127404A1 (de) * | 1991-08-19 | 1993-02-25 | Thomae Gmbh Dr K | Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
| DE4213931A1 (de) * | 1992-04-28 | 1993-11-04 | Thomae Gmbh Dr K | Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
| DE4213919A1 (de) * | 1992-04-28 | 1993-11-04 | Thomae Gmbh Dr K | Cyclische iminoderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
-
1992
- 1992-12-10 DE DE4241632A patent/DE4241632A1/de not_active Withdrawn
-
1993
- 1993-11-17 SK SK1281-93A patent/SK128193A3/sk unknown
- 1993-12-08 EP EP93119786A patent/EP0604800A1/de not_active Withdrawn
- 1993-12-08 CA CA002111035A patent/CA2111035A1/en not_active Abandoned
- 1993-12-08 NZ NZ250391A patent/NZ250391A/en unknown
- 1993-12-09 HU HU9303521A patent/HU9303521D0/hu unknown
- 1993-12-09 MX MX9307781A patent/MX9307781A/es unknown
- 1993-12-09 PL PL93301396A patent/PL301396A1/xx unknown
- 1993-12-09 IL IL10795693A patent/IL107956A0/xx unknown
- 1993-12-09 JP JP5308419A patent/JPH06239817A/ja active Pending
- 1993-12-09 NO NO934501A patent/NO934501L/no unknown
- 1993-12-09 KR KR1019930027010A patent/KR940014330A/ko not_active Application Discontinuation
- 1993-12-09 FI FI935513A patent/FI935513A/fi not_active Application Discontinuation
- 1993-12-09 ZA ZA939230A patent/ZA939230B/xx unknown
- 1993-12-09 NO NO934501D patent/NO934501D0/no unknown
- 1993-12-10 CN CN93120876A patent/CN1094035A/zh active Pending
- 1993-12-10 AU AU52306/93A patent/AU5230693A/en not_active Abandoned
- 1993-12-10 CZ CZ932705A patent/CZ270593A3/cs unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPH06239817A (ja) | 1994-08-30 |
| PL301396A1 (en) | 1994-07-25 |
| MX9307781A (es) | 1994-06-30 |
| KR940014330A (ko) | 1994-07-18 |
| IL107956A0 (en) | 1994-04-12 |
| HU9303521D0 (en) | 1994-04-28 |
| NO934501L (no) | 1994-06-13 |
| CN1094035A (zh) | 1994-10-26 |
| FI935513A0 (fi) | 1993-12-09 |
| DE4241632A1 (de) | 1994-06-16 |
| SK128193A3 (en) | 1995-02-08 |
| FI935513A (fi) | 1994-06-11 |
| NO934501D0 (no) | 1993-12-09 |
| AU5230693A (en) | 1994-06-23 |
| CA2111035A1 (en) | 1994-06-11 |
| NZ250391A (en) | 1996-06-25 |
| CZ270593A3 (en) | 1994-11-16 |
| EP0604800A1 (de) | 1994-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA937502B (en) | Carboxylic acid derivatives pharmaceutical compositions containing these compounds and processes for preparing them | |
| ZA939230B (en) | Carboxylic acid derivatives pharmaceutical compositions containing these compounds and processes for preparing them | |
| ZA93975B (en) | Benzimidazolyl derivatives pharmaceutical compositions containing these compounds and processes for preparing them | |
| ZA927994B (en) | Heterobiaryl derivatives pharmaceutical compositions containing these compounds and processes for preparing them | |
| HUT70526A (en) | Indole-2-carboxylic acid derivatives, process for producing thereof and pharmaceutical compositions comprising same compounds | |
| IL110296A (en) | Imidazole compounds process for their preparation and pharmaceutical compositions containing them | |
| HUT63632A (en) | Process for producing 5-amino-4-hydroxyhexanoic acid derivatives and pharmaceutical compositions comprising same | |
| IL100899A0 (en) | Beta-amino-alpha-hydroxycarboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
| HUT42101A (en) | Process for preparing stomatostatine derivatives and pharmaceutical compositions containing such compounds | |
| IL103932A0 (en) | Fatty acid derivatives and pharmaceutical compositions containing them | |
| ZA934090B (en) | Biphenyl derivatives pharmaceutical compositions containing these compounds and processes for preparing them | |
| HUT69712A (en) | Process for preparing benzimidazole derivatives and pharmaceutical compositions containing them | |
| IL108019A0 (en) | Hydroxyiminoalkylindole-carboxylic acid derivatives their preparation and pharmaceutical compositions containing them | |
| IL115072A (en) | Pharmaceutical compositions containing substituted 4-phenyl-6-amino-nicotinic acid derivatives their preparation some such new compounds and process for their preparation | |
| HUT41737A (en) | Process for preparing morphinane derivatives and pharmaceutical compositions containing such compounds | |
| SG43083A1 (en) | Benzinidaziles pharmaceutical compositions containing these compounds and processes for preparing them | |
| HUT42488A (en) | Process for preparing beta-lactam derivatives and pharmaceutical compositions containing such compounds | |
| HUT72319A (en) | Epoxy-succinic acid derivatives, pharmaceutical compositions containing them and process for their preparation | |
| ZA933638B (en) | Heterocyclic compounds a process for the preparation thereof and pharmaceutical compositions containing them | |
| ZA966154B (en) | Aminophenylphosphonic acid compounds process for preparing them and pharmaceutical compositions containing them | |
| HU9203866D0 (en) | Method for producing benzoic acid derivatives and pharmaceutical preparatives containing said compounds | |
| HU895952D0 (en) | Process for the preparation of substituted pyrrolidone-2-carboxylic acid derivatives and pharmaceutical compositions containing them | |
| IL102116A (en) | Hetaryloxy-beta-carboline derivatives processes for the preparation thereof and pharmaceutical compositions containing the same | |
| HU9400325D0 (en) | Process for producing amino-ascorbic acid derivatives and pharmaceutical compositions containing them | |
| EG20289A (en) | Process for preparing of novel pharmaceutical compositions comprising 3- substituted 2-oxindole -1- corboximides |